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Abstract. We model the intention of patients to use a telehealth app for the
management of a chronic disease. Our model integrates the health belief model
with a model of information technology acceptance to reflect the technology- and
health-related parts of the intention. The intention of non-using patients to use
the app is influenced by their hedonic motivation and social influence. An
analysis of sub-groups reveals deeper insights: Patients without access to the app
would use it based on the expected performance and their self-efficacy. Patients
who do not use the app despite having access to it would use it if influenced by
their social environment and if they perceive their disease to be severe. A third
group does not even know whether they can use the app. The results show that
proper education of patients and people influencing them is necessary even in the
case of chronic diseases.

Keywords: Chronic Disease Management, M-Health, Telehealth, Technology
Adoption, Patient Behavior
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Introduction

Treatment of chronic diseases has been continuously improved over the last decades,
with an increasing focus on patient self-care [1]. Chronic diseases differ from acute
diseases (that last only a short time) in their impact on patients as well as on the
healthcare system and are the most common cause of death worldwide [2]. M-health is
well suited to support chronic disease patients [3] and it is expected to improve their
treatment adherence [2]. It has also been shown analytically that m-health can be
superior to the office-visit model with respect to patient’s average life expectancy and
expected total lifetime utility [4]. The benefits come mostly from additional
opportunities for intervention by the health care provider. We concentrate on
hemophilia, as an exemplary chronic disease. It is often “neglected” by research on mhealth [5] because the number of patients is comparably low at 400,000 hemophiliacs
[6] vs. 400,000,000 diabetics [7] worldwide. The hemophilia treatment is named
replacement therapy because it replaces the blood clotting factors missing in
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hemophiliacs. Clotting factors help to close wounds and stop internal bleedings. The
required substance for hemophilia treatment, a synthetic blood clotting factor, is costly
and prone to overconsumption, since the precisely needed dose is difficult to determine,
but overdosing has no negative health consequences [8]. In a study regarding the
outpatient expenditures for 34,000 children with chronic diseases in California, only
145 children from this group had hemophilia but they accounted for 41% (195$ million)
of the state spending for this group [9]. M-health supported documentation offers
advantages to patients and the health care system, as they provide data about the success
of different therapy approaches and allow for a more precise dosage and thus less
overconsumption. This study uses combined models from health psychology and
information systems to analyze which conditions facilitate the application of m-health
for support of chronic diseases, esp. hemophilia.

2
2.1

Background
Hemophilia

Hemophiliacs are prone to longer bleedings after injuries and possible internal
bleedings, e. g., inside joints or the brain. This may result in disabling arthropathy and,
in severe cases, death [8]. Regular treatment (replacement therapies) produces better
results concerning the prevention of arthropathy (compared to on-demand), but patients
may not comply with the therapy and health care providers are hesitant to finance it [8].
This study researches hemophiliacs in Germany.
Chronic disease management (CDM) apps, here specifically for hemophilia
treatment, are an example of m-health support. Since September 2020, hemophiliacs in
Germany receive their prescription from hematologists and their factor supply in
pharmacies. Hematologists are organized in hemophilia treatment centers (HTC),
which range from big comprehensive care centers with approx. 40 patients and with
specialized personal to individual physicians with some hemostaseological experience.
They are required by the German blood transfusion law to report their patients’ factor
usage to the German Hemophilia Registry (DHR). For this purpose, HTCs depend on
an accurate documentation by the patients or their legal guardian. Patients also report
relevant occurrences like joint bleedings.
Now, most patients document their factor usage in a paper notebook, which the
nurses in the HTC use to update the patient data on each visit. This paper-based
documentation is prone to several errors. Adherence to documentation and treatment is
difficult to verify, since the only time patients must show their records is when visiting
their physician, which can be just once a year. Patients often make updates just before
the visit, which can result in wrong dates, for example. The notebooks do not provide
a standardized way of recording joint bleedings. Therefore, patients improvise and
often do not enter information that is precise enough.
Alternatively, two apps have been separately developed to facilitate the
documentation via easier input (scan of the factor charge number) and digital data
transfer to the centers. These apps offer additional features and advantages. For

example, physicians can utilize them to monitor patients’ adherence to regular
prophylactic therapy. Disabling arthropathy as the most common consequence of
hemophilia is also easier prevented by CDM apps, since they allow to precisely record
the bleedings: the patient simply taps the location of the bleeding on a body drawing,
which provides the physician with an overview of all occurrences. In addition, the data
can be immediately forwarded to a hematologist. The collected data can also help to
better monitor the cost effectiveness of different treatment regimens [10]. HTCs need
to have the corresponding infrastructure, and therefore, support only one of the apps or
none at all. Both apps are certified medical products.
To summarize, hemophilia is different from chronic diseases like diabetes, because
on one hand an exact tracing of the medication taken is needed (in the past blood
transfusions were sometimes contaminated with diseases of the blood donors). On the
other hand, overdosage “only” burdens insurances and society but not patients.
2.2

Research Problem

There is no law in Germany that mandates the use of an app. Even if an HTC supports
an app, it is not allowed to demand its use from a patient or to put a non-user into any
disadvantage compared to patients who use the app. Also, no physician can deny
treatment if a patient does not want to use the app. Each patient can decide absolutely
freely whether to use the app. Models of technology acceptance are well-suited to
describe this voluntary use of an app. One of the most advanced and comprehensive of
such models is UTAUT2 (Unified Theory of Acceptance and Use of Technology 2). It
is based on several previous behavior models like the technology acceptance model
(TAM), TAM2, and the theory of reasoned action (TRA) [11]. Its constructs cover IT
aspects as well as some psychological aspects. However, it does not contain healthrelated constructs which can be very important in the context of chronic diseases.
Psychology of medicine has developed models that take health believes into account,
specifically related to an illness or behavior which can lead to an illness. These models
can be used to measure intentions of people to change their behavior or to measure the
effectiveness of activities that try to make people adhere to medical advice. The
measures need not demand any use of technology by patients. For example, warnings
about consequences of smoking on cigarette packages do not expect any technology
use. For such purposes models like the health belief model (HBM) have been developed
[12]. The HBM was originally developed to explain and predict the acceptance of
medical recommendations [13]. It assumes that, health-related actions depend on an
individual’s perception of his own health status and assessment of these actions. This
perception is formed by how threatened individuals feel and how beneficial the possible
action may be. The threat is determined by the perceived seriousness and susceptibility
of the disease, and the decision is further weighted against costs and benefits of the
action. Additionally, the decision is influenced by cues to action, represented by health
events or physician advice [13].
Our research goal is to systematically develop an adoption model for the use of an
app in the context of a chronic disease. The app helps to manage a life-threatening
disease. The resulting model can be applied to gain knowledge in this specific context.

Modeling the use of treatment-supporting apps for (chronic) diseases, requires
consideration of IT and health-related issues [14].
In some cases, older acceptance models are used despite the existence of newer
models with better conceptual coverage. Leanness of the combined model was often
achieved by simply omitting some constructs. This is problematic because important
concepts may be missing, and explanations of the problem can be biased. TAM and
HBM show conceptual similarity between their constructs (e. g., perceived usefulness)
[15]. We create a combined model systematically by combining constructs which are
conceptually similar but retain the conceptual coverage of HBM and newer acceptance
models. This way, we achieve an adequate conceptual coverage and a relatively lean
model.

3

Model Building

We start with health-related constructs provided by the HBM, then continue with shared
constructs and discuss the technology-related constructs from UTAUT2 at the end.
The HBM-exclusive part of the model contains the health-specific constructs perceived
susceptibility and perceived seriousness. They may be viewed as an individual’s threat
appraisal, which is part of several HBMs [12]. It is an essential part of health behavior,
since every coping behavior (e. g., using an m-health app) needs to be induced by a
perceived threat [16]. The versions of HBM are not consistent in the operationalization
of the links between susceptibility, seriousness, threat, and behavior [17]. Following
previous studies, we measure susceptibility and seriousness as separate dimensions to
achieve a more differentiated prediction [16]. High values of susceptibility and
seriousness, positively influenced the behavioral intention in other cases [18]. The
construct of perceived threat originates in psychological research about fear, where the
influence of fear on behavior change is described in various contexts, including health
[16]. The perceived seriousness is viewed as the most common variable [16] and has
consistently been found to facilitate behavior change [19]. Accordingly, we hypothesize
that a hemophiliac perceiving his illness as more severe will more likely use the digital
documentation:
H1: Perceived seriousness has a positive effect on usage intention.
Perceived susceptibility constitutes the second component of fear [16, 20]. E. g., it
is used in the research of preventive breast cancer mammography [20]. The construct
has consistently shown to facilitate behavior change, the more a subject was aware of
and felt susceptible to a disease [12]. It does not make sense to consider the fear of
getting hemophilia, because it is hereditary. In our study, threat is specified as the threat
of disabling arthropathy caused by joint bleeding since this is a common and dangerous
consequence of hemophilia. If a patient perceives himself as more susceptible to suffer
from joint bleeding, he is more likely to switch to m-health documentation in order to
better monitor and prevent the bleedings Therefore, we propose:
H2: Perceived susceptibility has a positive effect on usage intention.
Self-efficacy describes the degree of a person’s ability to perform an intended
behavior [21]. It is an effective predictor of behavioral intention and has been later

added to the HBM [12], while it was included in the Protection Motivation Theory
(PMT), an alternative to HBM, from the beginning [16]. Users confident in their ability
to effectively use technology will be more likely to use that technology. This positive
influence has been validated in general models of technology acceptance [22] as well
as in studies focusing on m-health [12]. It has also been found to be the most decisive
predictor in studies researching long-term health behavior, e. g., dietary behavior [23].
Here, self-efficacy describes a patient’s ability to intuitively use smartphone apps. It is
assumed that a patient, who perceives himself as efficient in the use of apps and
smartphones in general, is more likely to also use the smartphone-based documentation.
H3: Self-efficacy has a positive effect on usage intention.
Next, we discuss constructs that are found both in HBM and UTAUT2. The
integration of these models allows for a reduction of latent constructs where they
conceptually overlap. The similarity of the constructs can be derived from their
definition and operationalization. The HBM constructs are viewed as easy to adapt for
specific use [17] and they have been shown to be valuable predictors using alternative
operationalizations [13].
Performance expectancy is defined as the degree to which an individual believes that
using a system will help him to increase performance [22]. It proved to be a strong
predictor of behavioral intention in studies with a healthcare context [24]. Perceived
benefits in the HBM were defined as the likelihood of an action to be taken depending
on an individual’s perception of the effectiveness of the action [13]. Therefore, both are
perceptions about effectiveness, differentiating only between an action and (IT) system.
In our study, the action is defined as using a system (the app), therefore the constructs
are similar. This notion of benefit has been used by various researchers to predict health
behavior [13, 18]. Here, benefits provided by the app are, for example, improved
bleeding monitoring and facilitated exchange with hematologists. An extensive
literature review in the domain of telehealth treatment of chronic diseases identified
perceptions of effectiveness as a possible facilitator to tele-homecare programs [25].
We assume, therefore, that an increase in the perceived benefits of an app-based
documentation will increase a patient’s intention to use it.
H4: Performance expectancy has a positive effect on usage intention.
Effort expectancy describes the ease of using a technology [11]. Perceived barriers
are defined as potential impeding aspects of a health action [13]. These can be described
as “difficulty of use” which is the opposite of ease of use. However, both descriptions
are guided by the same idea and can be operationalized in the same way. Documentation
apps face two types of barriers: the software must match the technical abilities of users
and their health knowledge. Technical barriers can be slow loading and responses while
a medical barrier may be the use of terms the patient is not familiar with. The apps need
to present easy interactions that give medically and technically clear instructions. We
assume that if the user expects such problems, his intention to use the app will decline.
H5: Effort expectancy has a negative effect on usage intention.
Social Influence (e. g., advice from family, friends, or physicians) has been found to
be another strong predictor of behavior intention [11]. In a recent study on patient
adoption decisions of a diabetes management app, it had the strongest positive influence
[26]. Concerning social influence, it is described as the degree to which an individual

perceives that important others believe he or she should use a new system [22], while
the cues to action encompass influence exerted by significant others [17]. Thus, the
constructs may be considered to be similar. Social influence is also found in general
behavioral theories like TRA and TPB, where subjective norm is included as perceived
social pressure to perform a certain behavior [27]. Advice is usually a positive,
awareness-raising factor and will, therefore, exert a positive influence [12]. In previous
studies, social influence has sometimes not been an important factor for determining
behavior regarding health technology [28], but those studies mainly applied UTAUT to
health care professionals. As this study focuses on patients, who normally heed their
physician’s advice, social influence is expected to take a more significant role. Another
study showed physicians to be viewed as reliable sources concerning health app
suggestions [29]. In sum, this study assumes advice from physicians and/or friends to
increase the intention of patients to use smartphone documentation, since they want to
satisfy their social group’s expectations.
H6: Social influence has a positive effect on usage intention.
The technology-exclusive part of our model consists of the UTAUT2 constructs
facilitating conditions and hedonic motivation. Facilitating conditions describe the
availability of physical resources aiding in the use of m-health (e. g., smartphone) as
well as support by friends or an introduction course given by the care center [11]. They
have been found to reliably predict behavior intention in a health-care context [12].
Here, facilitating resources specifically include an easy to use smartphone and the
possibility to ask for help when using the app. We assume that better resources and
support will increase the likelihood of using an app-based documentation.
H7: Facilitating conditions have a positive effect on usage intention.
Hedonic motivation describes the fun or pleasure derived from using a technology
[11], m-health in this case. It represents an intrinsic motivation within UTAUT [11].
Although our study is conducted in the context of CDM, hedonic motivation may be
present because apps represent a much newer technology than paper-based
documentation. Patients may find satisfaction in using new technology for managing
their disease. Therefore, a patient experiencing more pleasure in using apps is expected
to be more likely to use an app-based documentation:
H8: Hedonic motivation has a positive effect on usage intention.
UTAUT2 further proposes price value and habit as constructs. Price value is
excluded, since the sample only used m-health apps distributed by the HTCs free of
charge. Habit was dropped from the model, since there is no possibility for patients to
use a similar app before adoption and develop correlated habits. While fitness or health
tracking apps also serve tracking purposes, their use is not in a life-threatening context.
The consequences of not using them for days are usually not severe. All moderators
proposed by UTAUT2 were included except gender, because hemophilia only affects
males.
Figure 1 presents the complete research model while making the origins of concepts
explicit. It also shows where previous models are overlapping and can be made leaner
in our case.

Figure 1: Research model with UTAUT2/HBM overlap
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Sample & Data Collection

To test the proposed model and hypotheses, a survey was conducted with support of
the two major German hemophilia associations of patients. They have more than 3250
members in sum [30, 31] which includes patients, their relatives, and physicians. The
unique number of patients is not exactly known; we estimate it, based on talks with
experts, at about 3000. The associations aided in distributing the survey to their

members via mail, e-mail, or as a link on their home page but no follow-up was possible
because respondents were absolutely anonymous. The e-mail contained a link to the
online version of the survey, while the mail contained a printed version with a return
envelope. We received 144 responses in total. This amounts to less than 5% of the
population of unique patients in both associations. There are three possible reasons for
the relatively low return. First, most current users of the app did not care to participate
since they are aware of m-health in this case. Second, patients with the mild or moderate
form of hemophilia rarely use hemophilia medication and barely document anything.
Third, due to the rare occurrence of hemophilia relative to other chronic diseases, the
patients are frequently asked to participate in surveys for medical research. The survey
was designed to differentiate between users and non-users and contained accordingly
different questionnaire sections for them. From the total, 71 respondents were using an
app. These patients perceive to have a significantly better knowledge about hemophilia
than non-users. In this research, we were interested in the 73 respondents who do not
use any app to document their illness, yet. Eleven responses were excluded because of
suspicious answer patterns (always the same answer) and contradictory answers to
reverse questions, leaving n = 62.

5

Measures & Instruments

In addition to the questions related to the above research model, several socio-cultural
and health-specific items were asked. The additional questions include whether the
survey was answered by the hemophiliac himself or his legal guardian, the age, and the
way they document their disease now (app or paper). Furthermore, information on an
individual’s knowledge about hemophilia was collected since it was determined as a
possible variable in health behavior [32]. The participants were also asked to state their
objectively measured severity of hemophilia. Table 1 provides insight into the sample.
Table 1: Sample statistics

Variable
Age
Knowledge by
severity

Mean (SD) / distribution
39.6 (19.84)
Mild: 2.33 (0.71)
Moderate: 2.71 (0.76)
Severe: 2.94 (0.73)

Degree of
hemophilia

Health status

Measurement
Not existing (1) –
Perfect (5)
Mild (1), moderate
(2) and severe (3)

73.45 (24.13)

Bad (0) – Perfect
(100)

The (perceived) knowledge about hemophilia rises with the severity of the disease.
When adding non-users (62) and users (71), the percentage of severe cases in our survey
is 80%. This is higher than in the general population where the share of severe cases of
all hemophilia cases is estimated to be at 60%. First, the number of severe cases among
association members is probably bigger than in the general population because these
patients are more concerned with their disease and its treatment than patients with mild
or moderate hemophilia. Second, the interest of patients with severe hemophilia in new
CDM approaches is probably bigger than of other patients so they are more likely to
answer a related questionnaire.
Most model constructs were tested using scales derived from previous research. We
used the HBM’s main constructs perceived susceptibility, seriousness, benefits, and
barriers [33]. The measurement of perceived barriers and benefits is also used to
represent effort and performance expectancy, these constructs overlap with UTAUT2.
We follow previous studies in the e-health domain [34] and view self-efficacy as the
ability to use e-health applications. The scale was taken from a previous study [35] and
altered to specifically apply to CDM apps. The scales for measuring the factors
facilitating conditions and hedonic motivation are based on a previous UTAUT2 study
[11]. The scale for the integrated social influence/cues to action construct is adopted
from a study that also combines UTAUT and HBM [36].
It was necessary to decrease observation dropout due to missing values given the
small size of the sample. Therefore, Markov-Chain-Monte-Carlo imputation was used
to provide viable substitutes for missing values. The missing values were tested to be
missing at random. Ten values from eight respondents were imputed. Table 2 sums up
the used constructs and Cronbach’s α within the present study. The recommended
threshold for Cronbach’s α is 0.7, with values lower than that acceptable in exploratory
studies [37]. Only Social Influence does not provide a satisfying α but it is considered
close with a value of α=0.69. Facilitating Conditions and Self-Efficacy score the highest
means (Table 2), suggesting that the confidence and support to use digital
documentation is present.
Table 2: Variables

Variable
Usage intention
Perceived
Susceptibility
Perceived Seriousness
Performance
Expectancy
Effort Expectancy
Social Influence
Facilitating
Conditions
Hedonic Motivation
Self-Efficacy

Abbreviation
UI
PSus

Cronbach’s α
0.96
0.95

Mean (SD)
3.67 (1.66)
3.51 (1.64)

PSer
PExp

0.88
0.88

3.05 (1.23)
2.76 (1.14)

EExp
SI
FC

0.88
0.69
0.77

2.05 (0.88)
2.47 (1.10)
4.25 (1.14)

HM
SE

0.90
0.89

3.59 (1.37)
4.99 (0.90)

6

Analyses

Further analyses are conducted with PLS-SEM in SmartPLS3 and with Stata 14.1. First,
a correlation analysis is conducted to detect possible antecedents to behavioral
intention. While not providing predictive ability, the correlation analysis allows to
determine possible relationships. Second, a PLS-SEM is calculated to test the research
model. Third, several multiple regression analyses are carried out to extract more
information concerning relevant subgroups of the sample because their size is too small
for a PLS analysis. The correlation matrix between the variables given in the previous
chapter and behavioral intention is presented in Table 3.
Table 3: Correlation Matrix

UI

PSus

PSer PExp

EExp

SI

FC

HM

UI

1

PSus

0.16

1

PSer

0.26*

0.50***

1

PExp 0.47***

-0.09

0.00

1

EExp -0.29**

-0.21

-0.21

0.02

1

SI

0.39***

0.08

0.10

0.29*

-0.01

1

FC

0.06

0.07

0.07

0.04

-0.32**

0.22*

1

HM

0.67***

-0.07

0.14

0.60*** -0.44***

0.28**

0.17

SE

0.26**

0.09

0.11

-0.00

0.09

0.56*** 0.34**

-0.67***

SE

1
1

***p<0.01; **p<0.05; *p<0.10
Concerning the correlations, it is evident that the antecedents behave as intended
towards the outcome variable, with Effort Expectancy as the only antecedent with
negatively phrased items presenting the only negative correlation. Apart from
Perceived Susceptibility and Facilitating Conditions, all predictors show a significant
correlation. Hedonic Motivation and Performance Expectancy correlate best with
Usage Intention and show the highest level of significance together with Social
Influence. It is, therefore, likely that these factors are significant predictors of Usage
Intention.
Several antecedents show a high and significant correlation with each other,
therefore the VIF is calculated to test for multicollinearity. As Table 4 shows, no VIF
in the regression analysis is greater than ten, indicating no relevant multicollinearity
within the regression analysis [38]. In the PLS-SEM, no VIF exceeds 3.3, which
indicates that multicollinearity and common method bias have no relevant influence
there [39]. We further used Shapiro-Wilk to assess normality of the data, and several
non-normal distributions were found. While this will not impact the nonparametric
PLS, robust estimators were used in the regression analyses to address it. The
assumptions of linearity and homoscedasticity were tested for via plotting and the
Breusch-Pagan test. Both assumptions are fulfilled.

A PLS-SEM analysis is conducted to determine the relationship between antecedents
and Usage Intention. It is based on N = 62 with results shown in Figure 2. The
antecedents account for a variability of 68% of the Usage Intention (R² = 0.679). This
R² makes the sample size of 62 sufficient for a statistical power of 80% and with 5%
probability of error [40]. The significant positive predictors include Social Influence
and Hedonic Motivation. Therefore, H5 and H8 are supported. The antecedents
Perceived Susceptibility, Perceived Seriousness, Performance Expectancy, Effort
Expectancy, Facilitating Conditions and Self-Efficacy showed no predictive power for
Usage Intention. Therefore, hypotheses H1, H2, H3, H4, H7 and H6 are not supported
when analyzing the full sample.

Figure 2: Path coefficients and significances in the PLS-SEM analysis

However, the full sample is not homogenous with respect to the availability of an app
for documentation. On one hand, there are non-users who may want to use digital
documentation, but their HTC is not supporting it. On the other hand, there are nonusers who do not use an app although their HTC supports it. The situation of the two
groups of patients is objectively different so that a separate analysis is needed. A third
group is formed by patients who do not know whether their HTC offers an app. We
expected that hemophilia patients would be well informed about the disease and the
possibilities for its management (see also Table 1) but almost 30% of respondents
crossed the “do not know” option. Accordingly, the participants could be split in a subsample that does not use digital documentation despite its availability (Group DU),
another sub-sample with no access to it (Group NA) and a third group not knowing
whether it is available (Group DK). Due to the smaller sample size of the subgroups
(given in Table 4), we can only search for a large effect size and accept a higher
probability for Type II errors. Also, since smaller sample size can decrease the

significance level, we set the significance threshold to 0.1 in the regression analyses
[41]. Table 4 presents the different multiple regression analyses.
Hedonic Motivation is the only significant antecedent for the non-informed group.
It means that they do not understand what value the digital documentation may have
and, therefore, would only use it as a more entertaining way to document. Participants
with no current access to digital documentation expect it to be useful (Performance
Expectancy) and consider themselves to be well-prepared (Self-Efficacy) for it. Lastly,
participants who do not use digital documentation despite having access to it are
significantly influenced by Social Influence and Perceived Seriousness. The influence
by Facilitating Conditions has an unexpected negative sign which we suspect to be a
Simpson paradox, which was validated by additional single variable linear regression
[42]. Hence, we will exclude Facilitating Conditions from further discussion. The nonadoption by this group is surprising at first. A look at the illness severity in this group
explains this behavior to some extent. because 44% of participants do not have the
severe form (in other groups the share is only 21% and 12%) and do not really need
much documentation. If we add to this group app users, the share of severely ill patients
rises to 78%.
Table 4: Multiple Regression Analysis

Variable
Group DK
Perceived Susceptibility
0.14
Perceived Seriousness
-0.07
Performance Expectancy -0.05
Effort Expectancy
0.44
Social Influence
0.18
Facilitating Conditions
0.08
Hedonic Motivation
0.79**
Self-Efficacy
0.49
R²
0.77
Adj. R²
0.58
MaxVIF
3.52
N
19
% severe
78
***p<0.01; **p<0.05; *p<0.10
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Group DU
-0.28
0.73*
-0.52
-0.01
0.80**
-0.70*
0.97
0.62
0.74
0.51
6.42
18
56

Group NA
0.10
0.05
0.64*
-0.08
0.07
-0.42
0.05
0.88*
0.59
0.39
4.76
25
88

Discussion and Conclusions

The present study examined the factors determining the intention of patients to use mhealth for a chronic disease. Suitable factors from UTAUT2 and HBM were analyzed
in a PLS-SEM and in several multiple regressions. The analysis of the full sample of
non-users reveals that Social Influence and Hedonic Motivation are significant

predictors. The significant positive relationship of Social Influence confirms the
relevance of the social environment in deciding whether to use digital documentation.
The more suggestions patients receive from their friends, family members, or
physicians, the more inclined they are to use digital documentation. It shows a
significant difference between the role of Social Influence for professionals and
patients: while professionals seem to be little concerned about others’ opinions [28],
patients seem to rely more on advice, which makes sense given their lack of
professional knowledge. These results are in line with other studies researching mhealth usage from the patients’ perspective [12, 24], confirming that Social Influence
should be considered when researching m-health usage intention.
Hedonic Motivation shows to be the strongest and most significant predictor, which
matches the results of other adoption studies [5, 11]. It suggests that m-health apps need
to exceed their utilitarian value and provide additional features to gain the patients’
interest. This may seem surprising given the serious nature of chronic diseases, but also
fits the observed scenario: Patients will document their factor usage either way.
Digitalization cannot be achieved by only simply digitalizing the process, but it must
keep the patient engaged. M-health users value supportive functions like integrated
reminders and tracking [29].
The analysis of the full sample does not disclose perceptions of patients in a specific
situation. The sub-samples are small but still lead to some interesting and statistically
significant findings. The group with no access to digital documentation shows a
significant influence of Performance Expectancy on Usage Intention. This implies that
positive expectations about m-health are likely to lead to an increasing demand for such
possibilities. Given the close and often long relationship between physicians and their
patients, we do not believe that patients will switch to another physician (and HTC) for
that reason but we think when patients look for a new physician (e.g., because of
relocation) the opportunity to use an app for documentation will play a role. For the
group of patients with access to digital documentation but who do not use it, the concern
about hemophilia consequences (Perceived Seriousness) raises UI. For patients with
severe hemophilia in this group, it is probably just a question of smartphone skills, cost,
or time till they switch. Since they are open to Social Influence, some relating advice
may help to persuade them to switch to an app. The third group which is not informed
about the support of their HTC with respect to apps is puzzling. Whatever the real
situation in their HTC may be, they did not care to find out. This is understandable for
mild and moderate forms but not for the severe form of hemophilia (79% in this group!).
These people should know about the existence of apps for documentation from their
association (or other sources).
The present study offers several theoretical contributions and practical implications.
By combining UTAUT2 and HBM, the specific behavior in the health context is
represented in more detail than previously [43]. It follows the appeal to explore theorybased additions to health-IT use [14]. In comparison to studies on healthcare
professionals [12], our study shows that patients are different from professionals with
respect to m-health. This should be recognized when trying to persuade both groups to
use m-health or when conducting studies in this domain.

Compared to previous studies [44], our study shows the necessity of utilizing the full
UTAUT2 model instead of TAM or only parts of TAM2, since significant predictors
like hedonic motivation may be overlooked otherwise. Our study also shows a direct
impact of social influence on adoption intention instead of just an indirect one via
perceived usefulness. In other words, even if a patient does not perceive an app as
useful, he may still use it if the treating physician recommends it. We can also add that
the perceived usefulness, which was a central predictor to adoption attention in previous
studies [44], is only a significant predictor for patients who currently have no possibility
to use the respective CDM app (due to their treatment center). The study also provides
some insights useful to m-health providers and healthcare professionals on how to get
patients to adopt m-health. The significance of Social Influence demonstrates that app
providers need to reach out to treating physicians and the patients’ social environment,
which in the case of rare chronic diseases could be done via patient associations. App
providers should implement engaging and interesting additions to their apps. There are
already abundant implementations of such functions in the context of general health
applications. Similar features can be applied in the context of chronic diseases, where
the serious nature of the disease needs to be respected, but nonetheless information
should be presented in an interesting manner.
The limitations of the study are based on the measurement of intention rather than
use, the small sample, and the specific context. Participants with the intention to use an
app still must install and actually use the app. Therefore, a longitudinal design to track
actual usage after the intention has been formed is more reliable. Unfortunately, this is
especially difficult when respondents’ privacy must be assured without any
compromise. The number of respondents is a methodological restriction. Hence, the
findings of this study can only be considered as exploratory. A higher number of
participants would also allow for structural relationship modelling in subgroups, since
multiple regressions cannot fully map the factors’ relationships with each other.
Disease specifics do not allow a simple extension of the findings to other diseases.
Hemophilia patients already have the disease. Perceived susceptibility may play a
bigger role with a disease that can be contracted (e.g., various forms of cancer). The
download of the app cannot be done via an app store, but it must be provided by the
HTC due to the sensitivity of the data handled and the needed cooperation with the
HTC/physician. If an app can be offered via an app store, the rank of the app, its public
rating by other users, and similar factors may influence the adoption of such apps.
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